A randomized, phase 2 study comparing pemetrexed plus best supportive care versus best supportive care as maintenance therapy after first-line treatment with pemetrexed and cisplatin for advanced, non-squamous, non-small cell lung cancer

MLA

Mubarak Nabil, et al. “A Randomized, Phase 2 Study Comparing Pemetrexed plus Best Supportive Care versus Best Supportive Care as Maintenance Therapy after First-Line Treatment with Pemetrexed and Cisplatin for Advanced, Non-Squamous, Non-Small Cell Lung Cancer.” BMC Cancer, vol. 12, no. 1, Sept. 2012, p. 423. EBSCOhost, https://doi.org/10.1186/1471-2407-12-423.

APA

Mubarak Nabil, Gaafar Rabab, Shehata Samir, Hashem Tarek, Abigeres Dani, Azim Hamdy A, El-Husseiny Gamal, Al-Husaini Hamed, & Liu Zhixin. (2012). A randomized, phase 2 study comparing pemetrexed plus best supportive care versus best supportive care as maintenance therapy after first-line treatment with pemetrexed and cisplatin for advanced, non-squamous, non-small cell lung cancer. BMC Cancer, 12(1), 423. https://doi.org/10.1186/1471-2407-12-423

Chicago

Mubarak Nabil, Gaafar Rabab, Shehata Samir, Hashem Tarek, Abigeres Dani, Azim Hamdy A, El-Husseiny Gamal, Al-Husaini Hamed, and Liu Zhixin. 2012. “A Randomized, Phase 2 Study Comparing Pemetrexed plus Best Supportive Care versus Best Supportive Care as Maintenance Therapy after First-Line Treatment with Pemetrexed and Cisplatin for Advanced, Non-Squamous, Non-Small Cell Lung Cancer.” BMC Cancer 12 (1): 423. doi:10.1186/1471-2407-12-423.